Palbociclib After CDK and Endocrine Therapy (PACE)
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This research study is studying three combinations of drugs as treatments for breast cancer.
The drugs involved in this study are:
- Fulvestrant
- Fulvestrant with Palbociclib
- Fulvestrant with Palbociclib and Avelumab